NCT03999021View on ClinicalTrials.gov

FIGHT-RP 1 Extension Study

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 24, 2019

Primary Completion Date

August 31, 2026

Study Completion Date

June 30, 2027

Conditions
Retinitis Pigmentosa
Interventions
DRUG

NAC effervescent tablets

After completing the pretreatment visits, all patients will enter into the treatment phase where patients will receive 1800 mg of NAC effervescent tablets twice a day. The patients will be followed up every 3 months for 2 years. Therefore, there will be a total of 9 treatment visits (baseline, months 3, 6, 9, 12, 15, 18, 21 and 24).

Trial Locations (1)

21287

Wilmer Eye Institute at Johns Hopkins University, Baltimore

All Listed Sponsors
collaborator

Zambon SpA

INDUSTRY

lead

Johns Hopkins University

OTHER